Koppang N, Helgebostad A, Armstrong D, Rimeslåtten H
Acta Vet Scand. 1981;22(3-4):501-16. doi: 10.1186/BF03548675.
Single doses of DMNA from 8 to 15 mg/kg body weight (B.W.) were given in the feed, by stomach tube or by subcutaneous application to 37 foxes. The course and intensity of the disease was not influenced by the application route, but was directly related to the amount of DMNA given per kg body weight, and caused hemorrhagic centrolobular liver necrosis and acute vessel changes especially in the hepatic vein system. The possibility of liver regeneration after a single DMNA exposure depends on the degree of damage in the hepatic vein system. Some animals can recover from the acute disease caused by DMNA. But if the hepatic vessel changes are enough pronounced, progressive changes occur in the hepatic vein system eading to liver cirrhosis. The observation period of the foxes after a single exposure was from 13 to 380 days. LD should not be determined after a surviving time of 3 days but rather after 4 weeks. In our material LD was 10 mg DMNA/kg B.W. In an experiment over a longer period of time 18 foxes divided into 3 groups were given 2 weekly doses of DMNA in food. They were treated with daily estimated doses of 1.0, 0.2 and 0.1 mg DMNA/kg B.W., respectively. The foxes in Groups 1 and 2 developed ascites, jaundice and liver failure after intake of 45–70 mg DMNA/kg B.W. The foxes in Group 1 treated with 1 mg DMNA/kg B.W. showed centrolobular hemorrhagic liver necrosis and productive vessel changes in the hepatic vein system. The second group given 0.2 mg DMNA/kg B.W. developed hemorrhagic centrolobular necrosis which healed with fibrosis leading to cirrhosis and chronic occlusion in many of the hepatic veins. In addition noduli of chondroid lamellae and foci of hematopoietic tissue and early stages of hemagiomatous liver tumors were found in the liver. The group exposed with 0.1 mg DMNA/kg B.W./day did not develop hemorrhagic centrolobular liver necrosis, but thickening in the walls of the hepatic veins. After more than 3½ years of exposure multiple hemangiosarcomae were growing out from the changed vessel walls. In an experiment over a shorter time period with daily exposure of DMNA doses in the feed below 0.15 mg/kg B.W., all the foxes were completely healthy and only some showed beginning changes in the hepatic vein walls. Hematomae were often seen in foxes dying after a single DMNA dose. One fox treated with 0.1 mg DMNA/kg B.W. died of brain bleeding after 220 days of treatment. Chronic vessel changes were found in the heart and kidneys of the DMNA treated foxes. These results emphasize the fact that DMNA gives vessel changes of a more general nature.
给37只狐狸经饲料、胃管或皮下注射给予单剂量8至15毫克/千克体重(B.W.)的二甲硝基亚硝胺(DMNA)。疾病的病程和严重程度不受给药途径影响,而是与每千克体重给予的DMNA量直接相关,并导致肝小叶中央出血性坏死和急性血管变化,尤其是肝静脉系统。单次接触DMNA后肝脏再生的可能性取决于肝静脉系统的损伤程度。一些动物可以从DMNA引起的急性疾病中恢复。但如果肝血管变化足够明显,肝静脉系统会发生进行性变化,导致肝硬化。单次接触后狐狸的观察期为13至380天。不应在存活3天后测定半数致死剂量(LD),而应在4周后测定。在我们的材料中,LD为10毫克DMNA/千克体重。在一项较长时间的实验中,将18只狐狸分成3组,每周两次经食物给予DMNA。它们分别接受每日估计剂量为1.0、0.2和0.1毫克DMNA/千克体重的治疗。第1组和第2组的狐狸在摄入45 - 70毫克DMNA/千克体重后出现腹水、黄疸和肝功能衰竭。第1组接受1毫克DMNA/千克体重治疗的狐狸表现出肝小叶中央出血性坏死和肝静脉系统的增生性血管变化。给予0.2毫克DMNA/千克体重的第二组出现出血性肝小叶中央坏死,愈合后纤维化导致肝硬化,许多肝静脉出现慢性闭塞。此外,在肝脏中发现了软骨样板结节、造血组织灶和肝血管瘤早期阶段。每日接受0.1毫克DMNA/千克体重暴露的组未出现出血性肝小叶中央坏死,但肝静脉壁增厚。暴露超过3年半后,多个血管肉瘤从改变的血管壁上生长出来。在一个较短时间的实验中,每日经饲料给予低于0.15毫克/千克体重的DMNA剂量,所有狐狸完全健康,只有一些显示肝静脉壁开始出现变化。单次给予DMNA剂量后死亡的狐狸中经常可见血肿。一只接受0.1毫克DMNA/千克体重治疗的狐狸在治疗220天后死于脑出血。在接受DMNA治疗的狐狸的心脏和肾脏中发现了慢性血管变化。这些结果强调了DMNA会引起更普遍的血管变化这一事实。